Thus, inactivation of NF-κB in colon cancer cells by IKK inhibitors was demonstrated to blunt the ability of the cancer cells to grow by the antiapoptotic function of NF-κB. The gene discussed is NFKB1; the disease is malignant colon neoplasm.